SCHEMBL30797724

SCHEMBL30797724

CC(C)(C)OC(=O)NCCCCOCCOc1nc(-c2cnns2)cc2c1cnn2C1CCCCO1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 4/20 0.43
▸ SYK P43405 1/20 0.34
▸ FPR3 P25089 2/20 0.33
▸ FPR2 P25090 2/20 0.33
▸ ATRIP Q8WXE1 1/20 0.33
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33
▸ RXRG P48443 1/20 0.33
▸ CA12 O43570 3/20 0.32
▸ CA1 P00915 3/20 0.32
▸ CA2 P00918 3/20 0.32
▸ CA9 Q16790 3/20 0.32
▸ BRD4 O60885 3/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ DDB1 Q16531 1/20 0.32
▸ CRBN Q96SW2 1/20 0.32
▸ JAK2 O60674 1/20 0.31
▸ NTRK1 P04629 1/20 0.31
▸ CKS1B P61024 1/20 0.31
▸ SKP1 P63208 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30797892 0.89 ATR (0.42) ATRBRD4
SCHEMBL30797700 0.86 ATR (0.47) ATRFPR3FPR2ATRIPRXRA
SCHEMBL30797579 0.84 ATR (0.41) ATRSYKFPR3FPR2ATRIP
SCHEMBL27376610 0.78 ATR (0.51) ATRFPR3FPR2ATRIPRXRA
SCHEMBL30797968 0.78 ATR (0.51) ATRFPR3FPR2ATRIPRXRA
SCHEMBL30797874 0.77 ATR (0.48) ATRFPR3FPR2ATRIPRXRA
SCHEMBL27378404 0.76 ATR (0.46) ATRATRIPRXRARXRBRXRG
SCHEMBL30797746 0.76 ATR (0.46) ATRATRIPRXRARXRBRXRG
SCHEMBL30797685 0.76 ATR (0.46) ATRBRD4
SCHEMBL30797903 0.76 ATR (0.50) ATRATRIPRXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584266-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF Cambridge Enterprise Limited (GB) 2025-07-16 — — EP disclosed
WO-2024052701-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-03-14 — — WO disclosed
Send feedback